Diabetes

Diabetes is a disorder of metabolism—the way the body uses digested food for growth and energy. Most of the food people eat is broken down into glucose, the form of sugar in the blood. Glucose is the main source of fuel for the body.

What is Diabetes?

Diabetes is a condition where the body fails to utilize the ingested glucose properly. This could be due to lack of the hormone insulin or because the insulin that is available is not working effectively.

COVID-19 and Diabetes

What Causes Diabetes?

Diabetes Pathophysiology

Diabetes Diagnosis

Diabetes Screening

Diabetes Management

History of Diabetes

Diabetes Complications

Diabetes Symptoms

Diabetes Types

How does Gestational Diabetes Affect the Baby?

See more featured articles »

The Risks of Prediabetes

Diabetic Foot Problems

Diabetes and Skin Problems

Risks to Infants of Diabetic Mothers

Pins and Needles and Diabetes

Can I reverse my prediabetes naturally

Diabetic Emergencies: What to Do

Alcohol and Diabetes

Diabetes in Men

Diabetes in Men versus Women

Diabetes Risk Factors

Supplements for Diabetes

Low Sugar Foods for Diabetes

What is HbA1c?

Diabetes and Wound Healing

What is HbA1C Testing?

Adiponectin and Diabetes

Diabetes and Periodontitis

Red Blood Cell Morphology Changes in Diabetes

Diabetes and Sleep

Diabetes and Vision

Vitamin D and Type 2 Diabetes

What is a Diabetic Coma?

Diabetic Coma Severe Hypoglycemia

Advanced Diabetic Ketoacidosis

Nonketotic Hyperosmolar Coma

Cause of Diabetic Coma

Diabetic Coma Treatments

Causes of Foot Pain

What is Diabetic Hypoglycemia?

Diabetic Hypoglycemia Etiology

Diabetic Hypoglycemia Treatments

Hypoglycemic Unawareness

Animals That Can Detect Hypoglycemia

What is Diabetic Ketoacidosis?

Diabetic Ketoacidosis Causes

Diabetic Mastopathy: Complication of Diabetes Mellitus

Diabetic Mastopathy Diagnosis

Treatment and Prognosis for Diabetic Mastopathy

What is Diabetic Nephropathy?

Diabetic Nephropathy Treatment

Diabetic Nephropathy Symptoms

What Causes Diabetic Nephropathy (Kidney Disease)?

What is Diabetic Neuropathy?

Diabetic Neuropathy Pathogenesis

Diabetic Neuropathy Diagnosis

Diabetic Neuropathy Treatments

Diabetic Neuropathy Symptoms

What is Diabetic Retinopathy?

Diabetic Retinopathy Risk Factors

Diabetic Retinopathy Diagnosis

Diabetic Retinopathy Symptoms

Diabetic Retinopathy Treatments

Encapsulating Islet Cells for the Treatment of Diabetes

Effects of Hyperglycemia on the Vascular System

Diabetes and Pregnancy

The Future of Diabetes Treatment

Research into a Cure for Diabetes

Genetic Testing for Diabetes

Epigenetic Mechanisms in Type 2 Diabetes

What are Nightmares and Why Do They Occur?

Trailblazing Discoveries: The Top 5 Diabetes Research Breakthroughs of 2023

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Latest Diabetes News and Research

Early cardiovascular benefits of semaglutide seen within months in SELECT trial

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or obesity who have pre-existing cardiovascular disease but not diabetes, according to a secondary analysis of the landmark Semaglutide and Cardiovascular Outcomes (SELECT) trial from the same international author team being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.

12 May 2025

Lipid buildup predicts weaker bones once it passes a critical threshold

A large cross-sectional study using NHANES data found a non-linear negative relationship between lipid accumulation product (LAP) and lumbar spine bone mineral density (BMD). The association became significant only above a threshold value (ln-LAP > 2.846), independent of BMI.

12 May 2025

Study shows cardiovascular benefits of GLP-1RAs in patients following bariatric surgery

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and diabetes following bariatric surgery who did not achieve sufficient weight loss and diabetes control, according to new research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain.

12 May 2025

Study links gum disease symptoms to higher risk of multiple chronic conditions

A major new study presented at EuroPerio11, the world's leading congress in periodontology and implant dentistry by the EFP, has found that people with signs of gum disease are more likely to suffer from multiple chronic health conditions, a state known as multimorbidity.

12 May 2025

Tirzepatide outperforms semaglutide for weight loss in people without diabetes

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in adults with obesity but without diabetes. Over 72 weeks, tirzepatide helped more participants reach key weight loss milestones, with manageable side effects and strong metabolic benefits.

12 May 2025

Chokeberry juice reduces blood vessel resistance in people with pre-diabetes

A German crossover trial found that drinking polyphenol-rich red berry juice improved peripheral resistance and helped preserve muscle mass in pre-diabetic adults. No significant changes were seen in glucose control or oxidative stress over the 14-day interventions.

12 May 2025

Intermittent fasting may dampen inflammatory responses in the gums

New research presented today at EuroPerio11, the world's leading congress in periodontology and implant dentistry by the European Federation of Periodontology (EFP), suggests that intermittent fasting could help reduce inflammation in the gums and improve certain health markers, even when oral hygiene is temporarily neglected.

12 May 2025

Tirzepatide outperforms semaglutide in weight loss clinical trial

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial that compared the safety and efficacy of the injectable drugs.

12 May 2025

City of Hope opens largest outpatient facility to enhance cancer care

As advances in early detection and treatment transform cancer into a chronic disease, City of Hope, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the nation for cancer by U.S. News & World Report, opens its largest outpatient facility among its network of 38 U.S. locations.

12 May 2025

Millions of women may be unaware of their risk for cardiovascular-kidney-metabolic disease

Millions of women may be unknowingly living with risk factors for heart, kidney and metabolic disease – interconnected conditions that together drive risk for cardiovascular disease, the leading cause of death among women, according to experts with the American Heart Association, a global force changing the future of health for all.

12 May 2025

Research sheds light on the profound connections between diet, inflammation, and gum health

New research presented at EuroPerio11 sheds light on the profound connections between diet, inflammation, and gum health.

12 May 2025

GLP-1RAs show added protection against cancer beyond weight reduction

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) and published in the journal eClinicalMedicine finds that first generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss.

11 May 2025

Childhood obesity linked to lower employment and education rates in early adulthood

Individuals who lived with obesity as children are less likely to be in work or studying in their mid-20s than their peers, new research being presented at year's European Congress on Obesity (ECO 2025) has found.

11 May 2025

Adverse waist-to-height ratio trajectories during childhood linked to early cardiometabolic risk

New research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May) reveals that adverse waist-to-height ratio trajectories (a marker for central obesity) during childhood may increase cardiometabolic and cardiovascular risk at 10 years old.

11 May 2025

GLP-1 receptor agonists improve mood and metabolic health in adults with mental illness

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May).

11 May 2025

Early menopause increases risk of fatty liver disease and metabolic disorders

Women who experience menopause before the age of 50 - and especially before the age of 45 - are more likely to develop fatty liver disease and its related metabolic risk factors within one year after menopause, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE).

11 May 2025

Delayed puberty in boys raises risk of type 2 diabetes later in life, study shows

A large Israeli study found that boys who experience delayed puberty are significantly more likely to develop type 2 diabetes in early adulthood. This increased risk persists even after accounting for body weight, socio-economic status, and other confounding factors.

10 May 2025